Gareth Camp > Clifford Chance LLP > London, England > Lawyer Profile

Clifford Chance LLP
E14 5JJ

Work Department




Lawyer Rankings

London > Industry focus > Life sciences and healthcare

Clifford Chance LLP’s healthcare and life sciences group is praised by clients for its ability to ‘hit the ground running at full tilt in order to navigate strategic and commercial issues against incredibly tight time frames’. With notable experience acting for biotech, pharmaceutical, medical device and healthcare companies, the team leverages the firm’s wider network to advise on a range of global mandates spanning the entire product lifecycle. The practice is also recognised for its expertise in the health tech arena and the cannabis-based therapeutic market. Stephen Reese and Gareth Camp jointly lead the group, specialising in IP and corporate work, respectively.

London > Corporate and commercial > M&A: upper mid-market and premium deals, £500m+

(Next Generation Partners)

Gareth CampClifford Chance LLP

In the wake of an impressive run which has seen the team advising the likes of Telefónica, Cellnex, and Chrysaor Holdings on market-leading transactions, Clifford Chance LLP continues to handle numerous multi-billion pound deals for an impressive range of financial sponsors and FTSE 350 corporates. Practice co-chair Melissa Fogarty‘s recent highlights include big-ticket telecoms acquisitions and multi-jurisdictional divestitures in the financial services sector, while Tim Lewis‘ takeover expertise has seen him handling major cross-border deals for leading multinational insurers. A number of leading banks and retailers routinely turn to David Pudge for assistance in public takeovers and stock exchange matters. Steven Fox‘s comprehensive sector focus sees him handling public and private M&A work for a mix of international corporations, investment banks, and financial institutions. Gareth Camp is noted for his expertise in healthcare, consumer goods, and retail sector deals, while Katherine Moir‘s cross-border capabilities encompass public acquisitions, take-privates, and combinations. David Lewis left the practice in January 2022.